James B. Tananbaum

James B. Tananbaum has an estimated net worth of $281 Million. This is based on reported shares across multiple companies, which include 10x Genomics, Inc., AMBIT BIOSCIENCES CORP, PARDES BIOSCIENCES, INC., Intellia Therapeutics, Inc., Aclaris Therapeutics, Inc., Quantum-Si Inc, AERIE PHARMACEUTICALS INC, Kinnate Biopharma Inc., Gemini Therapeutics, Inc. /DE, Aimmune Therapeutics, Inc., Theseus Pharmaceuticals, Inc., and ALUMIS INC..

2019 was James B. Tananbaum's most active year for acquiring shares with 25 total transactions. James B. Tananbaum's most active month to acquire stocks was the month of July. 2020 was James B. Tananbaum's most active year for disposing of shares, totalling 32 transactions. James B. Tananbaum's most active month to dispose stocks was the month of March. 2024 saw James B. Tananbaum paying a total of $40,000,000.00 for 13,976,484 shares, this is the most they've acquired in one year. In 2020 James B. Tananbaum cashed out on 27,280,883 shares for a total of $177,508,500.00, their largest year based on trade value.